Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model

Tumour testing of the BRCA1/2 genes is routinely performed in patients with different cancer histological subtypes. To accurately identify patients with tumour-detected germline pathogenic variants (PVs) is a relevant issue currently under investigation. This study aims at evaluating the performance...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jacopo Azzollini, Andrea Vingiani, Luca Agnelli, Elena Tamborini, Federica Perrone, Elena Conca, Iolanda Capone, Adele Busico, Bernard Peissel, Erica Rosina, Monika Ducceschi, Mara Mantiero, Salvatore Lopez, Francesco Raspagliesi, Monica Niger, Matteo Duca, Silvia Damian, Claudia Proto, Filippo de Braud, Giancarlo Pruneri, Siranoush Manoukian
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-04-01
coleção:	Frontiers in Oncology
Assuntos:	ovarian cancer homologous recombination HBOC (hereditary breast and ovarian cancer) genetic counselling BRCA1 BRCA2
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fonc.2022.857515/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!